Clinical Trial Update: Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis [NA]

View source ↗

Summary

A completed clinical trial evaluating the CytoSorb hemoperfusion device for removing interleukin-6 in patients with acute respiratory distress syndrome or acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome
• Sepsis

Drugs mentioned

• CytoSorb Hemoperfusion Device (CytoSorb)

Snippet

Sponsor: MedaSorb Technologies, Inc | Conditions: Acute Respiratory Distress Syndrome, Acute Lung Injury | NA | Status: COMPLETED